During the past decade, National Hospital Organization Sendai Medical Center conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 16 clinical trials were completed, i.e. on average, 84.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Sendai Medical Center" #1 sponsor was "Pfizer" with 11 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Galapagos NV" with 3 trials sponsored and "Haruhiko Fukuda" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Sendai Medical Center" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Sendai Medical Center" are "Crohn's Disease" (5 trials), "Ulcerative Colitis" (5 trials), "Heart Failure" (4 trials), "Multiple Myeloma" (3 trials) and "Gastric Neoplasm" (2 trials). Many other conditions were trialed in "National Hospital Organization Sendai Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Sendai Medical Center" are "Drug" (27 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "CP-690,550" (5 trials), "Filgotinib" (4 trials), "Dexamethasone" (2 trials) and "Empagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Sendai Medical Center" are 29 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Sendai Medical Center". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in National Hospital Organization Sendai Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Sendai Medical Center, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".